New Thyroid Fine Needle Aspiration Biopsy Apparatus

Thyroid Cancer Clinical Trial

— fnab  

Official title:

New Thyroid Fine Needle Biopsy Apparatus

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01512212
• Other study ID #: thyroid.iiab
• Status: Recruiting
• Phase: N/A
• First received: January 10, 2012
• Last updated: January 13, 2012
• Start date: January 2012
• Est. completion date: September 2012

Study information

• Verified date: January 2012
• Source: SB Istanbul Education and Research Hospital
• Contact: erhan aysan, prof
• Phone: 902122531700
• Email: dr[@]webcerrah.com
• Is FDA regulated: No
• Health authority: Turkey: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

Evaluation of the effectivity of the new thyroid fine needle aspiration biopsy (FNAB) apparatus of which patented from Turkish Patent Institute.

Description:

The author group of this investigation produced a new thyroid fine needle aspiration biopsy (FNAB) apparatus and patented it from Turkish patent Institute. FNAB indicated nodular goitre patients are the subjects of this research. First, the investigators will perform standart FNAB after this procedure will perform FNAB with new apparatus. The investigators will evaluate the aspirates according to number of cells and malignity ratio of cells.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: September 2012
• Est. primary completion date: June 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 17 Years to 85 Years

Eligibility

Inclusion Criteria:

• fine needle aspiration biopsy indicated noduler goiter patients

Exclusion Criteria:

• diffuse goiter

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Thyroid Cancer
• Thyroid Diseases
• Thyroid Neoplasms

Intervention

Procedure:
• biopsy
fnab

Locations

Country	Name	City	State
Turkey	Bezmialem Vakif University	Istanbul	Marmara

Sponsors (2)

Lead Sponsor	Collaborator
SB Istanbul Education and Research Hospital	Bezmialem Vakif University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of cells	number of aspirated cells will be compared	2	No
Secondary	type of cells	type (benign, suspect, malign) of cells will be compared	2	No